Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress

Source: Nasdaq GlobeNewswire / 14 Jun 2024 02:01:00   America/Chicago